Back to companies

Enanta Pharmaceuticals Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Enanta Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Enanta Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Bruce L. A. Carter, Ph.D.

Chairman Executive Board Since: 2015 Age: 81

Jay R. Luly, Ph.D

Chief Executive Officer; President; Director Executive Board Since: 2003 Age: 68

Paul J. Mellett

Chief Administrative Officer; Chief Financial Officer Senior Management Since: 2024 Age: 69

Matthew P. Kowalsky

Secretary; Chief Legal Officer Senior Management Since: 2024 Age: 52

Scott T. Rottinghaus, M.D.

Chief Medical Officer Senior Management Since: 2022 Age: 51
Gain a 360-degree view of Enanta Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Enanta Pharmaceuticals Inc and make more informed decisions for your business Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer